NO911252L - Benzoksazinderivater, fremgangsmaate for fremstilling derav, samt anvendelse av derivatene. - Google Patents

Benzoksazinderivater, fremgangsmaate for fremstilling derav, samt anvendelse av derivatene.

Info

Publication number
NO911252L
NO911252L NO91911252A NO911252A NO911252L NO 911252 L NO911252 L NO 911252L NO 91911252 A NO91911252 A NO 91911252A NO 911252 A NO911252 A NO 911252A NO 911252 L NO911252 L NO 911252L
Authority
NO
Norway
Prior art keywords
derivatives
benzoksazin
procedures
preparing
benzoksazin derivatives
Prior art date
Application number
NO91911252A
Other languages
English (en)
Other versions
NO911252D0 (no
Inventor
Heinrich Christian Englert
Dieter Mania
Wolfgang Linz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO911252D0 publication Critical patent/NO911252D0/no
Publication of NO911252L publication Critical patent/NO911252L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/16—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with only hydrogen or carbon atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO91911252A 1990-03-31 1991-03-27 Benzoksazinderivater, fremgangsmaate for fremstilling derav, samt anvendelse av derivatene. NO911252L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4010488A DE4010488A1 (de) 1990-03-31 1990-03-31 Benzoxazinderivate, verfahren zu ihrer herstellung und ihre verwendung zum behandeln oder zur prophylaxe von krankheiten

Publications (2)

Publication Number Publication Date
NO911252D0 NO911252D0 (no) 1991-03-27
NO911252L true NO911252L (no) 1991-10-01

Family

ID=6403536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911252A NO911252L (no) 1990-03-31 1991-03-27 Benzoksazinderivater, fremgangsmaate for fremstilling derav, samt anvendelse av derivatene.

Country Status (14)

Country Link
EP (1) EP0450487A1 (no)
JP (1) JPH04221380A (no)
KR (1) KR910016719A (no)
AU (1) AU7387491A (no)
CA (1) CA2039319A1 (no)
CS (1) CS84891A2 (no)
DE (1) DE4010488A1 (no)
FI (1) FI911533A (no)
HU (1) HU911053D0 (no)
IE (1) IE911067A1 (no)
IL (1) IL97734A0 (no)
NO (1) NO911252L (no)
PT (1) PT97195A (no)
ZA (1) ZA912363B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104296D0 (sv) 2001-12-18 2001-12-18 St Jude Medical Pacemaker
PL2464645T3 (pl) 2009-07-27 2017-12-29 Gilead Sciences, Inc. Skondensowane heterocykliczne związki jako modulatory kanałów jonowych
CN103096977B (zh) 2010-07-02 2017-02-15 吉利德科学公司 作为离子通道调节剂的稠杂环化合物
MX361350B (es) 2011-05-10 2018-12-04 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal de sodio.
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (no) 2011-07-01 2018-04-28
EP3224644A4 (en) 2014-11-12 2018-11-07 Emscan Corporation Reactive near-field antenna measurement

Also Published As

Publication number Publication date
ZA912363B (en) 1991-12-24
FI911533A0 (fi) 1991-03-28
JPH04221380A (ja) 1992-08-11
DE4010488A1 (de) 1991-10-02
CS84891A2 (en) 1991-11-12
AU7387491A (en) 1991-10-03
KR910016719A (ko) 1991-11-05
CA2039319A1 (en) 1991-10-01
PT97195A (pt) 1991-11-29
IL97734A0 (en) 1992-06-21
NO911252D0 (no) 1991-03-27
HU911053D0 (en) 1991-10-28
IE911067A1 (en) 1991-10-09
EP0450487A1 (de) 1991-10-09
FI911533A (fi) 1991-10-01

Similar Documents

Publication Publication Date Title
NO913234L (no) Fremgangsmaate for fremstilling av pyrazolderivater.
DE122004000043I2 (de) Carbostyril-Derivate.
NO904987D0 (no) Fremgangsmaate for fremstilling av indolderivater.
NO912051L (no) Fremgangsmaate for fremstilling av azolderivater.
NO892936L (no) Fremgangsmaate for fremstilling av furanderivater.
NO912346D0 (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO913302D0 (no) Anti-fungale triazolderivater, samt fremstilling og anvendelse derav.
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO893826L (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO911252D0 (no) Benzoksazinderivater, fremgangsmaate for fremstilling derav, samt anvendelse av derivatene.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO893835L (no) Sic-pulver, fremgangsmaate for fremstilling derav samt anvendelse av pulveret.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO911672L (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO875230D0 (no) Imidazolderivater, samt fremgangsmaater for fremstilling derav.
NO900219L (no) Dihydroksybenzofenon-oksim, samt fremgangsmaate for fremstilling av slike oksimer.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO875068L (no) Buet antiabrasjonsprofil samt fremgangsmaate for fremstilling av samme.
NO901859D0 (no) Festebaand, samt fremgangsmaate for fremstilling av slikt festebaand.
NO913429D0 (no) Fremgangsmaate for fremstilling av 5-benzyl-substituerte benzimidazolin-2-tion-derivater.